BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 18941890)

  • 21. The embryonic pregnancy signal oestradiol influences gene expression at the level of translational initiation in porcine endometrial cells.
    Wollenhaupt K; Brüssow KP; Tiemann U; Tomek W
    Reprod Domest Anim; 2007 Apr; 42(2):167-75. PubMed ID: 17348974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GRB-7 facilitates HER-2/Neu-mediated signal transduction and tumor formation.
    Bai T; Luoh SW
    Carcinogenesis; 2008 Mar; 29(3):473-9. PubMed ID: 17916906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ERK1/2 inhibition increases antiestrogen treatment efficacy by interfering with hypoxia-induced downregulation of ERalpha: a combination therapy potentially targeting hypoxic and dormant tumor cells.
    Kronblad A; Hedenfalk I; Nilsson E; Påhlman S; Landberg G
    Oncogene; 2005 Oct; 24(45):6835-41. PubMed ID: 16007158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
    Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
    Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
    Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
    Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcium-independent phospholipase A2beta-Akt signaling is involved in lipopolysaccharide-induced NADPH oxidase 1 expression and foam cell formation.
    Lee SH; Park DW; Park SC; Park YK; Hong SY; Kim JR; Lee CH; Baek SH
    J Immunol; 2009 Dec; 183(11):7497-504. PubMed ID: 19917703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rictor and integrin-linked kinase interact and regulate Akt phosphorylation and cancer cell survival.
    McDonald PC; Oloumi A; Mills J; Dobreva I; Maidan M; Gray V; Wederell ED; Bally MB; Foster LJ; Dedhar S
    Cancer Res; 2008 Mar; 68(6):1618-24. PubMed ID: 18339839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential estrogenic effects of the persistent organochlorine pesticides dieldrin, endosulfan, and lindane in primary neuronal cultures.
    Briz V; Molina-Molina JM; Sánchez-Redondo S; Fernández MF; Grimalt JO; Olea N; Rodríguez-Farré E; Suñol C
    Toxicol Sci; 2011 Apr; 120(2):413-27. PubMed ID: 21278053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells.
    Kim KK; Lee JJ; Yang Y; You KH; Lee JH
    Carcinogenesis; 2008 Apr; 29(4):704-12. PubMed ID: 18258606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of HER2 and estrogen receptor alpha depends upon nuclear localization of Y-box binding protein-1 in human breast cancers.
    Fujii T; Kawahara A; Basaki Y; Hattori S; Nakashima K; Nakano K; Shirouzu K; Kohno K; Yanagawa T; Yamana H; Nishio K; Ono M; Kuwano M; Kage M
    Cancer Res; 2008 Mar; 68(5):1504-12. PubMed ID: 18316615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteasome-independent down-regulation of estrogen receptor-alpha (ERalpha) in breast cancer cells treated with 4,4'-dihydroxy-trans-stilbene.
    Balan KV; Wang Y; Chen SW; Chen JC; Zheng LF; Yang L; Liu ZL; Pantazis P; Wyche JH; Han Z
    Biochem Pharmacol; 2006 Aug; 72(5):573-81. PubMed ID: 16822479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TFAP2C controls hormone response in breast cancer cells through multiple pathways of estrogen signaling.
    Woodfield GW; Horan AD; Chen Y; Weigel RJ
    Cancer Res; 2007 Sep; 67(18):8439-43. PubMed ID: 17875680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphorylation of estrogen receptor alpha, serine residue 305 enhances activity.
    Tharakan R; Lepont P; Singleton D; Kumar R; Khan S
    Mol Cell Endocrinol; 2008 Nov; 295(1-2):70-8. PubMed ID: 18755239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines.
    Leivonen SK; Mäkelä R; Ostling P; Kohonen P; Haapa-Paananen S; Kleivi K; Enerly E; Aakula A; Hellström K; Sahlberg N; Kristensen VN; Børresen-Dale AL; Saviranta P; Perälä M; Kallioniemi O
    Oncogene; 2009 Nov; 28(44):3926-36. PubMed ID: 19684618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transactivation of ERalpha by Rosiglitazone induces proliferation in breast cancer cells.
    Talbert DR; Allred CD; Zaytseva YY; Kilgore MW
    Breast Cancer Res Treat; 2008 Mar; 108(1):23-33. PubMed ID: 17453334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach.
    Tozlu S; Girault I; Vacher S; Vendrell J; Andrieu C; Spyratos F; Cohen P; Lidereau R; Bieche I
    Endocr Relat Cancer; 2006 Dec; 13(4):1109-20. PubMed ID: 17158757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of 2-hydroxyethyl methacrylate on human pulp cell survival pathways ERK and AKT.
    Spagnuolo G; D'Antò V; Valletta R; Strisciuglio C; Schmalz G; Schweikl H; Rengo S
    J Endod; 2008 Jun; 34(6):684-8. PubMed ID: 18498889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated ERK1/ERK2/estrogen receptor cross-talk enhances estrogen-mediated signaling during long-term estrogen deprivation.
    Martin LA; Farmer I; Johnston SR; Ali S; Dowsett M
    Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S75-84. PubMed ID: 16113101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibronectin and type IV collagen activate ERalpha AF-1 by c-Src pathway: effect on breast cancer cell motility.
    Sisci D; Aquila S; Middea E; Gentile M; Maggiolini M; Mastroianni F; Montanaro D; Andò S
    Oncogene; 2004 Nov; 23(55):8920-30. PubMed ID: 15467744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Filamin A is a novel caveolin-1-dependent target in IGF-I-stimulated cancer cell migration.
    Ravid D; Chuderland D; Landsman L; Lavie Y; Reich R; Liscovitch M
    Exp Cell Res; 2008 Sep; 314(15):2762-73. PubMed ID: 18598695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.